rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
18
|
pubmed:dateCreated |
1995-10-6
|
pubmed:abstractText |
Spontaneous tumorigenesis was evaluated in male p53-knockout (p53-/-) mice treated with dehydroepiandrosterone (DHEA), quercetin, d-limonene, or all-trans retinoic acid to determine whether tumor development in these mice can be modulated by cancer-chemopreventive agents. DHEA-treated mice experienced a delay in tumorigenesis (particularly lymphomas) and subsequent mortality (P < 0.01) relative to untreated control mice. Quercetin, d-limonene, and all-trans retinoic acid each had no effect on spontaneous tumor development in p53-/- mice. These data demonstrate that tumor development in p53-/- mice can be delayed by DHEA and suggest that p53-/- mice provide a useful model for evaluating strategies to offset the increased risk of tumorigenesis resulting from loss of p53 tumor suppressor function.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-5472
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
55
|
pubmed:geneSymbol |
p53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3949-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7664260-Animals,
pubmed-meshheading:7664260-Anticarcinogenic Agents,
pubmed-meshheading:7664260-Cyclohexenes,
pubmed-meshheading:7664260-Dehydroepiandrosterone,
pubmed-meshheading:7664260-Gene Deletion,
pubmed-meshheading:7664260-Genes, p53,
pubmed-meshheading:7664260-Male,
pubmed-meshheading:7664260-Mice,
pubmed-meshheading:7664260-Mice, Inbred C57BL,
pubmed-meshheading:7664260-Neoplasms,
pubmed-meshheading:7664260-Quercetin,
pubmed-meshheading:7664260-Terpenes,
pubmed-meshheading:7664260-Tretinoin
|
pubmed:year |
1995
|
pubmed:articleTitle |
Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.
|
pubmed:affiliation |
Laboratory of Nutritional and Molecular Regulation, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|